{"id":"W4388033556","doi":"10.1038/s41591-023-02660-6","title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; Ono Pharmaceutical; Canadian Association of Thoracic Surgeons; G1 Therapeutics; Genentech; F-star Therapeutics; Regeneron Pharmaceuticals; U.S. Department of Defense; Sanofi; LUNGevity Foundation; Society for Immunotherapy of Cancer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Mark Foundation For Cancer Research; Mesothelioma Applied Research Foundation; Pfizer; Amgen","keywords":"Medicine; Lung cancer; Neoadjuvant therapy; Nivolumab; Oncology; Internal medicine; Chemotherapy; Hazard ratio; Cancer; Response Evaluation Criteria in Solid Tumors; Pathology; Progressive disease; Immunotherapy; Confidence interval; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001035065,0.0001533422,0.0004199764,0.0002116555,0.00003062597,0.00000580569,0.00003879519,0.0003004779,0.0001579921],"category_scores_gemma":[0.0003574776,0.000095822,0.00003676378,0.0004933472,0.00003743046,0.00003356313,0.0000229937,0.0004720984,0.000006803532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005262168,"about_ca_system_score_gemma":0.00006644991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001760593,"about_ca_topic_score_gemma":0.0001586887,"domain_scores_codex":[0.9986905,0.0001393711,0.0002082947,0.0002922016,0.0004070055,0.0002625525],"domain_scores_gemma":[0.9990478,0.0005417002,0.00007246609,0.0001661585,0.00007415497,0.00009777459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009504238,0.00003605776,0.9829774,0.00004569265,0.0001400866,0.0004653568,0.0007238375,6.222801e-7,0.0004030828,0.000005159098,0.006235899,0.008016308],"study_design_scores_gemma":[0.005171415,0.0004793576,0.9859387,0.000454715,0.0001633127,0.000003963459,0.00007330757,0.00001801299,0.0002590496,0.00005014093,0.007301779,0.00008620362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9183528,0.01944399,7.495328e-7,0.06106645,0.0004621856,0.0004104419,0.00002570584,0.00006945273,0.00016818],"genre_scores_gemma":[0.9862499,0.009934487,0.00001425599,0.001827812,0.0006288625,0.0001846983,0.00005140889,0.00001893262,0.00108966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06789704,"threshold_uncertainty_score":0.3907508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01404497636871023,"score_gpt":0.3485324132110651,"score_spread":0.3344874368423549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}